DNA vaccines: developing new strategies against cancer. - Wikidata - awgldk - TriplyDB

DNA vaccines: developing new strategies against cancer.

DNA vaccines: developing new strategies against cancer.

http://www.wikidata.org/entity/Q33756622

about

DNA vaccine for cancer immunotherapy Consensus HIV-1 FSU-A integrase gene variants electroporated into mice induce polyfunctional antigen-specific CD4+ and CD8+ T cells DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS.Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.Chemokines as Cancer Vaccine Adjuvants.A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.Improvement of different vaccine delivery systems for cancer therapy.Vaccines targeting the neovasculature of tumors Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer Classification of current anticancer immunotherapies Trial watch: Naked and vectored DNA-based anticancer vaccines Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study.Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.Microbial synthetic biology for human therapeutics.DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.A DNA vaccine against Escherichia coli O157:H7.Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticles Construction and Production of Foxp3-Fc (IgG) DNA Vaccine/Fusion Protein Trial watch: DNA vaccines for cancer therapy.Pre-clinical toxicity & immunobiological evaluation of DNA rabies vaccine & combination rabies vaccine in rhesus monkeys (Macaca mulatta).Clitocybe nuda Activates Dendritic Cells and Acts as a DNA Vaccine Adjuvant.A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model.In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses.Antigens in chronic myeloid leukemia: implications for vaccine development.Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines.Immunotherapy for multiple myeloma.Production and purification of plasmid DNA vaccines: is there scope for further innovation?Electroporation-enhanced delivery of nucleic acid vaccines.Vectors and strategies for nonviral cancer gene therapy.Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity.Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.DNAhsp65 Vaccine as Therapy against Paracoccidioidomycosis.Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma.

P2860

Q28080919-4764D70A-EBE5-4A5B-B4E7-0208182944FE Q28487823-8953BB09-2974-464A-B793-99F97F53450F Q28547011-ADD53C97-23C2-400F-8DE0-1C98BE5FC259 Q30204348-5FC0BF1E-8DA3-4FF0-8FBE-68DEF89231D8 Q30352934-66FB1FDE-F477-46B4-809A-992382B380A1 Q30408029-7EA8424D-FC03-48EA-B5D5-C20CE0C2610E Q33779343-5647CD36-02B6-4A85-93F3-F1359364EB95 Q33792344-22D52EED-7676-4DDC-BEC8-0C7BDFEB605E Q34369139-71825A87-0B65-42E1-901B-749B1ABCCE9F Q34506877-BFD729C1-988F-4B4B-8918-992324A7813C Q34704905-F900102A-E0DB-4A1E-8463-60B4E1367EBD Q35065923-2BB99920-B295-41DE-97EF-82FFE8677C75 Q35149637-BA4C8FA1-2C3C-4684-9D6F-2559CD1E615F Q35798986-ECE45448-D38F-4FD2-9EFA-063C2EDEBA69 Q35863376-9E846AE1-C919-49F9-B592-2D7EEB21D916 Q35887085-6A44E1CB-709B-466D-BECC-E8A5D6D842A6 Q36179139-4BF4A7D7-25EB-4384-A721-71771E0538A1 Q36544893-D8B6C729-7DC2-4CDE-9ED8-8E6BADB1AA10 Q36668517-E94A083F-5512-449D-9553-2ABCEBC297B0 Q36777146-299EAF1C-5DE3-4615-A0FA-5827E31EC7BD Q36821063-50D2A325-6C5E-47FB-8B4C-326A1E888C11 Q36822999-0CD48B8B-1CC1-4A6A-94EE-A5ADA33BE094 Q36828834-BE2D1D0F-F357-489C-B529-ECFE7298A13A Q36845824-07528BB0-5B68-4CA4-B130-5A20639BB554 Q37073211-48DABE4C-CB3A-40A1-94DB-BBCC42D319F7 Q37154827-D775A9AE-4D9A-46D5-98D3-CF5140BB8E41 Q37530511-8580F569-9AB5-4A3E-84C9-81A48373285E Q37547141-E768F3A2-6A1E-4A0F-ADB8-C4B10E8388C8 Q37950233-43CABAE8-F491-49B2-93AC-37224B63D1CB Q38076053-BB4AE04C-F2A3-448B-9BE1-85268329B889 Q38177879-D6C8927F-944E-4343-8B2B-0C9424CB1C74 Q38259502-10AC1E8D-E06D-4467-A128-9AC8DB800016 Q38285418-16F0F954-1E1D-49BE-850F-C2C72A711AC1 Q38694798-D05DC837-7AC3-4D4C-A574-16C7D8216DA9 Q38985050-64B8B67D-CFEB-4812-A1ED-C211B4A2B1E8 Q39365796-36A45929-E2AC-40BA-A41A-D10E326A03F1 Q39396051-8B978B7E-F58D-4F20-9964-E7A0426B2849 Q39637966-96FFBEBA-7FE3-448F-9548-B0B7C280776A Q40274361-81404B28-F38F-4AB0-A81E-4D4FF812C66A Q40302619-81CFA509-8561-4D1C-AFDC-9D275EC66202

P2860

DNA vaccines: developing new strategies against cancer.

http://www.wikidata.org/entity/Q33756622

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

DNA vaccines: developing new strategies against cancer.

@ast

DNA vaccines: developing new strategies against cancer.

@en

type

label

DNA vaccines: developing new strategies against cancer.

@ast

DNA vaccines: developing new strategies against cancer.

@en

prefLabel

DNA vaccines: developing new strategies against cancer.

@ast

DNA vaccines: developing new strategies against cancer.

@en

P1433

Q33756622-D78C85CB-6982-4B8A-8D06-D790D0855B2A

P1476

Q33756622-388F4F3C-825F-4266-AC02-F8BB86A77E2E

P2093

Q33756622-23D63922-0946-4D3A-BCC4-5E0352E1FD21

Q33756622-B30FB8B8-8C8C-47D0-920D-C2D772ED04C7

Q33756622-CBA14A8D-A48F-497B-80AF-36EB83B86456

Q33756622-D8089FDF-61D0-4FEA-8B9A-8E653CBE63AD

P2860

Q33756622-030F4E32-901F-4BDD-B79E-2BD14E6A9BD5

Q33756622-04D32E03-1A93-4155-9091-77F7BAB53263

Q33756622-064E4E8A-0352-45B8-ADED-FFA32C545137

Q33756622-092DCC8A-DBC0-498F-9CD2-64F336F4565C

Q33756622-097DD675-2886-4D6B-88E5-CF08BC129637

Q33756622-0ABBF14C-1BDB-42E6-B6F0-E00D839BBA5C

Q33756622-0AD8AA03-4388-49C5-A7D9-2D16D3274ED4

Q33756622-0C2DE9E0-C0E8-4C7F-ABF9-863868D335FF

Q33756622-0DE7134A-73DC-4D79-85AA-75B41D8CC2F8

Q33756622-0F8548D6-8E0A-413B-AD34-E5422E2337EA

P304

Q33756622-21635F80-59B5-4149-93AB-0987444E72C6

P31

Q33756622-BCC6E0FA-A5B2-4EED-9D4E-6486A7CEFC12

Q33756622-D7439795-4ACA-43B6-A560-4054D127C5DF

P356

Q33756622-71FE12AD-6BEE-49EE-993D-CA96C73123B5

P478

Q33756622-A342E952-5DFC-43F8-B087-18A6F9E55AF2

P577

Q33756622-C2FEAA99-C402-4450-81EA-045D9651F551

P5875

Q33756622-49F1692C-653A-4631-89D2-B965EE29F896

P698

Q33756622-57BD8F57-4531-44AC-A11B-C4F3E76357D5

P921

Q33756622-126EB588-4395-4AE4-83FD-749BD4FC5962

Q33756622-E66463BF-7D3A-4944-8B28-D0F6E15FBF00

P932

Q33756622-77EE95EB-2CBB-4118-A523-8B09DFD98B31

P356

P1433

Journal of Biomedicine and Biotechnology

P1476

DNA vaccines: developing new strategies against cancer.

@en

P2093

Daniela Fioretti

http://www.w3.org/2001/XMLSchema#string

Monica Rinaldi

http://www.w3.org/2001/XMLSchema#string

Sandra Iurescia

http://www.w3.org/2001/XMLSchema#string

Vito Michele Fazio

http://www.w3.org/2001/XMLSchema#string

P2860

Strategies of tumor immune evasion.

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

Dr William Coley and tumour regression: a place in history or in the future

Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts

DNA vaccines: immunology, application, and optimization*

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Immunosuppressive networks in the tumour environment and their therapeutic relevance

P304

174378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/174378

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43023730

http://www.w3.org/2001/XMLSchema#string

P698

20368780

http://www.w3.org/2001/XMLSchema#string

P921

recombinant protein

P932

2846346

http://www.w3.org/2001/XMLSchema#string